Clinical data | |
---|---|
Trade names | Draximage DTPA |
License data | |
Routes of administration | Intravenous, inhalation |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C14H18N3NaO10Tc |
Molar mass | 509 g·mol−1 |
3D model (JSmol) | |
| |
|
Technetium (99mTc) pentetic acid, sold under the brand name Draximage DTPA among others, is a radiopharmaceutical medication used in nuclear medicine to image the brain, kidneys, or lungs.[1] It is given by intravenous injection or via aerosol spray.[1] It consists of technetium-99m bound to the conjugate base of pentetic acid, with sodium as an additional cation.
Technetium (99mTc) pentetic acid is indicated for use in the diagnosis of the brain, kidneys, or lungs.[1]